ImaginAb to Present at Upcoming Investor and Scientific Conferences in April and May 2019

On April 17, 2019 ImaginAb Inc., a clinical stage immuno-oncology imaging company, reported that it is scheduled to present at the following investor and scientific conferences in April and May 2019 (Press release, ImaginAb, APR 17, 2019, View Source [SID1234535165]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

AIM at Melanoma

April 26-28, 2019, Hotel L’Echiquier Opera Paris, 38 Rue De L Echiquier, Paris

Dr. Anna Wu, Founder, and Board Director, and Ivan Plavec, CBO will be attending and making a presentation on ImaginAb at the 26th International Myeloma Working Group meeting in Paris.

Anglo-Nordic Life Science Conference

May 9, 2019, The County Hall, Belvedere Road, London

Ian Wilson, CEO, will be a panelist at the ‘Technologies and Treatments – What’s on the horizon’ discussion at 13.30 BST.

Bio€quity Europe 2019

May 20-21, 2019, Crowne Plaza Fira Center, Barcelona

Ian Wilson, CEO, and Ivan Plavec, CBO, will be attending and hosting meetings.

2019 ASCO (Free ASCO Whitepaper) Annual Meeting

May 31-June 4, 2019, McCormick Place, Chicago

Ian Wilson, CEO, Ivan Plavec, CBO, and Ron Korn CMO, will be attending and hosting meetings.

Inquiries:

ImaginAb

Ian Wilson

Email: [email protected]

Phone: +1 310 645 1211

Optimum Strategic Communications

Mary Clark, Supriya Mathur

Email: [email protected]

Phone: +44 20 3950 9144